Association of Stress-Related Disorders

Association of Stress-Related Disorders

Original Investigation | March 9, 2020

Key Points

Question  Do severe psychiatric reactions induced by trauma or other life stressors increase the risk for neurodegenerative diseases?

Findings  In a nationwide cohort study of individuals with stress-related disorders and those without such disorders, the exposed individuals were at a considerably higher risk of developing neurodegenerative diseases compared with their matched unexposed counterparts. This risk elevation was more pronounced for vascular neurodegenerative diseases (risk increase of 80%) than for primary neurodegenerative diseases (risk increase of 31%).

Meaning  These findings suggest that stress-related disorders may be associated with the subsequent risk of neurodegenerative diseases, possibly through a cerebrovascular pathway.

Abstract

Importance  Posttraumatic stress disorder (PTSD) has been associated with increased risk for dementia. Less is known, however, about other stress-related disorders and their associations with neurodegenerative diseases.

Objective  To examine the association between stress-related disorders and risk for neurodegenerative diseases.

Design, Setting, and Participants  This population-matched and sibling cohort study was conducted in Sweden using data from nationwide health registers, including the Swedish National Patient Register. Individuals who received their first diagnosis of stress-related disorders between January 1, 1987, and December 31, 2008, were identified. Individuals who had a history of neurodegenerative diseases, had conflicting or missing information, had no data on family links, or were aged 40 years or younger at the end of the study were excluded. Individuals with stress-related disorders were compared with the general population in a matched cohort design; they were also compared with their siblings in a sibling cohort. Follow-up commenced from the age of 40 years or 5 years after the diagnosis of stress-related disorders, whichever came later, until the first diagnosis of a neurodegenerative disease, death, emigration, or the end of follow-up (December 31, 2013), whichever occurred first. Data analyses were performed from November 2018 to April 2019.

Exposures  Diagnosis of stress-related disorders (PTSD, acute stress reaction, adjustment disorder, and other stress reactions).

Main Outcomes and Measurements Neurodegenerative diseases were identified through the National Patient Register and classified as primary or vascular. Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis were evaluated separately. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) with 95% CIs after controlling for multiple confounders.

Results  The population-matched cohort included 61 748 exposed individuals and 595 335 matched unexposed individuals. A total of 44 839 exposed individuals and their 78 482 unaffected full siblings were included in the sibling cohort analysis. The median (interquartile range) age at the start of follow-up was 47 (41-56) years, and 24 323 (39.4%) of the exposed individuals were male. The median (interquartile range) follow-up was 4.7 (2.1-9.8) years. Compared with unexposed individuals, individuals with a stress-related disorder were at an increased risk of neurodegenerative diseases (HR, 1.57; 95% CI, 1.43-1.73). The risk increase was greater for vascular neurodegenerative diseases (HR, 1.80; 95% CI, 1.40-2.31) than for primary neurodegenerative diseases (HR, 1.31; 95% CI, 1.15-1.48). A statistically significant association was found for Alzheimer disease (HR, 1.36; 95% CI, 1.12-1.67) but not Parkinson disease (HR, 1.20; 95% CI, 0.98-1.47) or amyotrophic lateral sclerosis (HR, 1.20; 95% CI, 0.74-1.96). Results from the sibling cohort corroborated results from the population-matched cohort.

Conclusions and Relevance  This study showed an association between stress-related disorders and an increased risk of neurodegenerative diseases. The relative strength of this association for vascular neurodegenerative diseases suggests a potential cerebrovascular pathway.

 

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.

PSP Awareness Shop

Make a purchase with purpose. Each sale supports the fight against Atypical Parkinsonism through the Coleen Cunningham Foundation for PSP Awareness!

Shop Now
  • DR-HO'S Pain Therapy System Pro

    DR-HO'S Pain Therapy System Pro

    Laura Louizos

    DR-HO'S Pain Therapy System Pro is a versatile device for pain relief. It uses TENS, EMS, and AMP to target and alleviate pain. Easy to use with customizable settings for...

    DR-HO'S Pain Therapy System Pro

    Laura Louizos

    DR-HO'S Pain Therapy System Pro is a versatile device for pain relief. It uses TENS, EMS, and AMP to target and alleviate pain. Easy to use with customizable settings for...

  • Article on PSP awareness in Star Weekly Australia

    Article on PSP awareness in Star Weekly Australia

    Laura Louizos

    Exciting News from the Coleen Cunningham Foundation!   We are thrilled to announce that a fantastic article on PSP awareness has been published in an Australian newspaper, organized by Peter...

    Article on PSP awareness in Star Weekly Australia

    Laura Louizos

    Exciting News from the Coleen Cunningham Foundation!   We are thrilled to announce that a fantastic article on PSP awareness has been published in an Australian newspaper, organized by Peter...

  • Navigating Atypical Parkinsonism: Misdiagnosis Challenges and Family Frustrations

    Navigating Atypical Parkinsonism: Misdiagnosis ...

    Laura Louizos

    Challenges in diagnosing atypical parkinsonism. Misdiagnosis issues and their impact on families. Common symptoms mistaken for other diseases. The importance of specialized medical expertise. How families can advocate for accurate...

    Navigating Atypical Parkinsonism: Misdiagnosis ...

    Laura Louizos

    Challenges in diagnosing atypical parkinsonism. Misdiagnosis issues and their impact on families. Common symptoms mistaken for other diseases. The importance of specialized medical expertise. How families can advocate for accurate...

  • Understanding Progressive Supranuclear Palsy: Symptoms, Management Tips, and FAQs

    Understanding Progressive Supranuclear Palsy: S...

    Laura Louizos

    - Progressive Supranuclear Palsy (PSP) is a rare neurological disorder affecting movement, balance, and eye movements. - Symptoms include stiffness, balance issues, difficulty moving eyes, speech and swallowing difficulties, and...

    Understanding Progressive Supranuclear Palsy: S...

    Laura Louizos

    - Progressive Supranuclear Palsy (PSP) is a rare neurological disorder affecting movement, balance, and eye movements. - Symptoms include stiffness, balance issues, difficulty moving eyes, speech and swallowing difficulties, and...

1 of 4